CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 26 - 50 of 740
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C01539 Temperature measurement

Measurement of the participant's/subject's body temperature

Supplemental Electrophysiology General (For all diseases) General (For all diseases)
C01539 Temperature measurement

Measurement of the participant's/subject's body temperature

Supplemental Vital Signs General (For all diseases) General (For all diseases)
C18670 Subscribed drug or substance illicitly used category other text

The free-text field related to 'Subscribed drug or substance illicitly used category' specifying other text. Category of illegal drugs, prescription, or over-the-counter drugs the participant/subject used for purposes other than those for which they are meant to be used, or in large amounts

Supplemental Behavioral History General (For all diseases) General (For all diseases)
C00712 Subscribed drug or substance illicitly used category

Category of illegal drugs, prescription, or over-the-counter drugs subscribed by the participant/subject, and used for purposes other than those for which they are meant to be used, or in large amounts

Supplemental Behavioral History General (For all diseases) General (For all diseases)
C21121 Subject zip postal code number

The number of the subject/participant's zip/postal code

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C21123 Subject other phone number

The other phone number of the subject/participant

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C21117 Subject name

Name of subject/participant

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C21118 Subject mailing address name

Name of the mailing address of subject/participant

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C21120 Subject home state province name

The name of the state or province that the subject/participant inhabits

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C21122 Subject home phone number

The home phone number of the subject/participant

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C21119 Subject home city name

Name of city in which the subject/participant lives

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C21124 Subject email address name

The name of the email address of the subject/participant

Supplemental Participant/Subject Contact Information General (For all diseases) General (For all diseases)
C05123 Study therapy session expected duration

Duration expected of the study therapy session in minutes according to study protocol

Supplemental Study Therapies Compliance General (For all diseases) General (For all diseases)
C05120 Study therapy session actual duration

Duration of the actual study therapy session in minutes

Supplemental Study Therapies Compliance General (For all diseases) General (For all diseases)
C05122 Study therapy administered date and time

Date (and time, if applicable and known) the study therapy was administered to the participant/subject

Supplemental Study Therapies Compliance General (For all diseases) General (For all diseases)
C19256 Study protocol name

Name of study protocol

Supplemental Serious Adverse Events General (For all diseases) General (For all diseases)
C02215 Study eligibility indicator

Indicator of whether the participant/subject is eligible for participation in the clinical research protocol according to its inclusion and exclusion criteria

Supplemental Inclusion and Exclusion Criteria General (For all diseases) General (For all diseases)
C02017 Study drug start date and time

Date (and time, if applicable and known) on which the study drug usage begins

Supplemental Study Drug Dosing General (For all diseases) General (For all diseases)
C02005 Study drug returned date and time

Date (and time, if applicable and known) on which the study drug was returned

Supplemental Study Drug Compliance General (For all diseases) General (For all diseases)
C02021 Study drug expected taken count

Count of expected amount of study drug taken

Supplemental Study Drug Compliance General (For all diseases) General (For all diseases)
C02020 Study drug expected returned count

Count of expected amount of study drug returned

Supplemental Study Drug Compliance General (For all diseases) General (For all diseases)
C02009 Study drug end date and time

Date (and time, if applicable and known) the administration of the study drug ended

Supplemental Study Drug Dosing General (For all diseases) General (For all diseases)
C02026 Study drug dose unit of measure UCUM code

Code that represents the dosage unit of measure of the study drug administered

Supplemental Study Drug Dosing General (For all diseases) General (For all diseases)
C02023 Study drug dose unit of measure

Unit of measure of the study drug dosage administered

Supplemental Study Drug Dosing General (For all diseases) General (For all diseases)
C02012 Study drug dose frequency

Frequency of use of study drug

Supplemental Study Drug Dosing General (For all diseases) General (For all diseases)
Displaying 26 - 50 of 740

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.